Programme Introduction
About this programme
💊 Pharmacy Practice
✅ Regulatory & Clinical
📋 Case-Based Learning
Regulatory affairs professionals are the bridge between a pharmaceutical company’s scientific work and the regulators who decide whether a medicine can be marketed. In India, this means navigating the Central Drugs Standard Control Organization (CDSCO) approval framework; internationally, it means working within harmonised guidance from bodies such as ICH. This certification preparation programme builds fluency in both the domestic dossier process and the international principles that increasingly shape it.
Without a clear grasp of approval pathways, dossier structure, and compliance obligations, submissions get delayed, queried, or rejected — costing companies time-to-market and costing professionals credibility. TerraLeap’s programme works through the CDSCO regulatory structure, drug approval pathways, clinical trial permissions, and the Common Technical Document format that underlies most modern regulatory dossiers.
Learners practise assembling dossier sections, tracking a submission through its regulatory lifecycle, and identifying the compliance gaps that commonly trigger regulator queries, building the judgement a certification assessment is designed to test.
By the end, learners can explain the CDSCO approval pathway for a new drug, structure a regulatory dossier correctly, and articulate how ICH guidelines inform post-marketing regulatory responsibilities.
Clinical and regulatory expertise — built for real pharmacy practice.
Programme Scope
What this programme covers
This certification preparation spans CDSCO regulatory structure, drug approval pathways, dossier preparation, and post-marketing regulatory obligations.
🏛️
CDSCO regulatory structure
How India’s central and state drug authorities are organised and where their approval powers sit.
✅
Drug approval pathways
Routes to market for new drugs, generics, and fixed-dose combinations, and how each differs procedurally.
🧬
Clinical trial permissions
Regulatory requirements for initiating and conducting clinical trials in India.
📁
Dossier preparation
Structuring a regulatory submission with the quality, safety, and efficacy data reviewers expect.
🌍
ICH harmonisation principles
How internationally harmonised guidance shapes dossier format and quality expectations.
🏷️
Labelling requirements
Statutory labelling and packaging information that must accompany a regulatory submission.
🔄
Post-marketing responsibilities
Pharmacovigilance reporting, variation filings, and lifecycle management after approval.
Learning Objectives
What you will achieve
This programme prepares learners for the Regulatory Affairs Certification Exam by building applied, dossier-level regulatory competence.
Each objective mirrors a task a regulatory affairs professional performs when preparing or managing a submission.
01
Explain the CDSCO structure and how central and state authorities share approval responsibility.
02
Map the correct approval pathway for a new drug, generic, or fixed-dose combination.
03
Structure a regulatory dossier with the quality, safety, and efficacy sections reviewers expect.
04
Identify clinical trial permission requirements before a trial can begin in India.
05
Apply ICH principles to dossier format and quality documentation expectations.
06
Draft compliant labelling and packaging information for a submission.
07
Manage post-marketing obligations including pharmacovigilance and variation filings.
08
Anticipate regulator queries by recognising common gaps in submission quality.
Target Audience
Who can enroll
TerraLeap’s Regulatory Affairs Certification preparation is built for pharmacy and regulatory affairs professionals who prepare, submit, or manage drug approval dossiers.
It also suits students and career-changers aiming to move into regulatory affairs functions within pharmaceutical companies or consulting firms.
📁
Regulatory affairs executives preparing CDSCO submissions and dossiers.
🎓
B.Pharm and M.Pharm graduates seeking to enter regulatory affairs careers.
🧬
Clinical research professionals coordinating trial approvals and permissions.
🏭
Pharmaceutical manufacturers preparing product registration filings.
📊
Quality assurance professionals coordinating with regulatory teams on compliance documentation.
🌍
Professionals aiming for regulatory roles at multinational pharmaceutical companies.
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
Regulatory Affairs Certification Examination
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.